Tesamorelin half-life is about 26 to 38 minutes, so the peptide clears your body within hours. Learn what changes that timing and what it means for dosing.
Tesamorelin has a reported half-life of about 26 to 38 minutes after subcutaneous injection, so the peptide is cleared from the bloodstream within a few hours. This short window is typical for a synthetic growth hormone-releasing hormone (GHRH) analog, and it is one reason tesamorelin is dosed once daily. Even though the drug itself disappears quickly, its downstream effects on IGF-1 can last longer.
Below is a plain-language breakdown of the tesamorelin half-life, what it means for how long the drug stays in your system, and how it compares with other peptides and hormones.
What "Half-Life" Means for Tesamorelin
Half-life is the time it takes for the body to eliminate half of a drug dose from the bloodstream. For tesamorelin, that number is measured after a subcutaneous injection, which is the only approved route of administration.
Published pharmacokinetic data and the FDA label describe a half-life of roughly 26 to 38 minutes. Peak plasma concentrations typically occur within 15 to 30 minutes after injection. Tesamorelin is broken down by proteolytic enzymes in the blood and tissues rather than being cleared mainly by the kidneys.
Pharmacokinetic studies in healthy adults and in people with HIV have produced similar estimates, which is why the 26-to-38-minute range appears in the prescribing information. Because the half-life is short, tesamorelin does not build up in the body when it is injected once daily. Steady-state accumulation is minimal.
How Long Does Tesamorelin Stay in Your System?
Using the standard rule that a drug is mostly eliminated after about five half-lives, tesamorelin is largely cleared within roughly 2 to 3 hours. Small amounts may still be detectable for a short time after that, depending on the sensitivity of the test.
It helps to separate the drug from its effects. Tesamorelin itself has a short half-life, but it triggers a pulse of growth hormone and a rise in IGF-1. IGF-1 levels can stay elevated for many hours after the peptide is gone.
So when people ask how long does tesamorelin stay in your system, the honest answer has two parts: the peptide clears in hours, while the hormonal response it sets off can last much longer. Routine blood tests do not usually screen for tesamorelin, so most people are really asking about duration of effect rather than detection.
What Can Affect Tesamorelin's Half-Life?
Half-life values are averages. Individual results can vary based on several factors:
- Injection site and blood flow: Absorption from subcutaneous tissue can differ between the abdomen and the thigh.
- Body composition: More subcutaneous fat may slightly slow absorption.
- Liver and kidney function: Although tesamorelin is not mainly cleared by the kidneys, severe organ impairment can change how any drug is handled.
- Age and overall health: Older adults and people with other medical conditions may process peptides differently.
These factors usually shift the half-life by minutes, not hours. They do not change the basic fact that tesamorelin is a short-acting peptide.
How Tesamorelin Compares to Other Peptides and Hormones
Half-life is one of the clearest ways to tell peptide drugs apart. The table below shows approximate values for tesamorelin and several related compounds.
| Compound | Reported half-life | Typical dosing |
|---|---|---|
| Tesamorelin | About 26–38 minutes | Once daily subcutaneous |
| Somatropin (rhGH) | About 2–4 hours subcutaneous | Once daily subcutaneous |
| AOD-9604 | About 30 minutes | Research only; once or twice daily |
| Cagrilintide | About 7–8 days | Once weekly subcutaneous (investigational) |
| Tirzepatide | About 5 days | Once weekly subcutaneous |
| Melanotan II | About 1 hour | Not FDA-approved |
| DSIP | Minutes | Research only |
| Epitalon | Minutes | Research only |
The somatropin half-life is measured in hours rather than minutes, largely because somatropin is a larger protein. By contrast, the tirzepatide half-life stretches to about five days, which is why tirzepatide is injected weekly. Researchers who study aod 9604 half-life see a profile closer to tesamorelin's, while the cagrilintide half-life is closer to that of a long-acting weekly medication. The melanotan ii half life is short, but that drug is not approved for human use.
Why the Short Half-Life Matters for Dosing
Tesamorelin is typically injected once daily, often at a consistent time. The short half-life means a single dose does not provide around-the-clock drug levels. Instead, each injection produces a pulse of growth hormone release.
Missing a dose does not leave a large reservoir of drug in the body, and the medication does not need to be tapered when it is stopped. Some clinicians recommend evening dosing to better match the body's natural overnight growth hormone rhythm, while others focus on a consistent daily schedule. The best timing is a decision to make with a healthcare professional.
Safety and What to Know Before Using Tesamorelin
Tesamorelin is FDA-approved under the brand name Egrifta for a specific condition: excess visceral abdominal fat in adults living with HIV. It is not approved for general weight loss, athletic performance, or anti-aging.
Common side effects include injection-site reactions, joint pain, muscle pain, and swelling. Tesamorelin can raise IGF-1 levels and may increase the risk of diabetes, so blood sugar monitoring is often recommended.
Tesamorelin is not appropriate for everyone. It is contraindicated during pregnancy and breastfeeding, in people with active cancer, and in certain pituitary conditions. Anyone considering tesamorelin should discuss risks, benefits, and alternatives with a licensed healthcare professional.
Half-life is only one part of the picture. A drug's effect depends on dose, receptor activity, and individual health. Even a short-acting peptide can have meaningful effects, and those effects should be monitored by a clinician.
Frequently Asked Questions
What is the half-life of tesamorelin?
The reported half-life of tesamorelin is about 26 to 38 minutes after a subcutaneous injection. Most of the drug is cleared from the body within a few hours. The exact time can vary slightly based on the person and the injection site.
How long does tesamorelin stay in your system?
Using the standard five-half-life estimate, tesamorelin is largely eliminated in roughly 2 to 3 hours. The hormonal effects, including higher IGF-1 levels, can last longer than the peptide itself. Routine drug tests usually do not screen for tesamorelin.
Does tesamorelin need to be injected every day because of its short half-life?
Yes. Tesamorelin is typically injected once daily because a single dose does not stay active for 24 hours. Each injection produces a growth hormone pulse, and the exact schedule should be confirmed with a healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.